Live webinar on patient preferences in European HTA

PREFER’s Nigel Cook is one of the featured presenters at this live webinar on patient preferences in health technology assessment (HTA) in Europe, the recent advances and future potential. 

(Image removed)

Want to understand when and how patient preference information can support HTA submissions? Want to learn how to collect patient preference information to support HTA, or learn about possible future developments in the use of preference information in HTA?

Attend this live webinar on 15 Octobre, at 16:00 CEST!

Both presenters are active in recent efforts to understand and extend the use of PPI in HTA. Kevin Marsh recently co-chaired an ISPOR working group that reviewed the use of preference data in HTA across Europe. Nigel Cook is a member of IMI PREFER and was the sponsor Principal Investigator on NICE's recent scientific advice on a patient preference study.

Read more & register

CONTACT US

X: @IMI_PREFER

LinkedIn

YouTube

  •  
  • Disclaimer: This website and its contents reflects the PREFER project's view and not the view of IMI, the European Union or EFPIA.
  •  

PREFER

The Patient Preferences in Benefit-Risk Assessments during the Drug Life Cycle (PREFER) project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 115966. This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA).